Hunan Hansen Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 002412.SZ

Hunan Hansen Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2023: 11.56%

Hunan Hansen Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) is 11.56% for the year ending December 31, 2023, a 131.40% change year over year. Return on capital employed assesses profitability against invested capital; higher ROCE signals efficient capital use.

Hunan Hansen Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2022 was 4.99%, a -43.61% change year over year.
Hunan Hansen Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2021 was 8.86%, a 15.06% change year over year.
Hunan Hansen Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2020 was 7.70%, a -39.06% change year over year.
Hunan Hansen Pharmaceutical Co., Ltd. Return on Capital Employed (ROCE) for the year ending December 31, 2019 was 12.63%, a 11.81% change year over year.

Key data

Date	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio	Return on Common Equity

Shenzhen Stock Exchange: 002412.SZ

Hunan Hansen Pharmaceutical Co., Ltd.

CEO	Mr. Zhengqing Liu
IPO Date	May 25, 2010
Location	China
Headquarters	No. 2688, Yincheng Avenue
Employees	1,536
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Drugstores & Retail Pharmacies

Description

Hunan Hansen Pharmaceutical Co., Ltd. produces and sells Chinese and chemical medicine preparations in China and internationally. It provides medicines in injection, oral liquid, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. The company is based in Yiyang, China.

Key trends

Past 5 years